1. Medtech Insight

Galaxy Gets $18M To Advance Centauri Pulsed Field Ablation System

 
• By Reed Miller

ATP, a venture capital firm focused on life sciences, is providing the series A round to help Galaxy complete European and Canadian trials of its Centauri pulsed field ablation technology to treat atrial fibrillation.

electrophysiology map of atrial fibrillation
EP map, created by Abbott's Ensite, of a four-vein isolation ablation in Galaxy Medical's European study of the Centauri PFA system. • Source: Galaxy Medical

Galaxy Medical has secured an $18m series A financing to advance its Centauri pulsed field ablation (PFA) technology for treatment of atrial fibrillation.

The investment comes from ATP, a New York-based venture capital firm with $2

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Financing

More from Business